1-year results from HELIOS trial show stability or improvement in treating NPDR
The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was well tolerated.
The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was well tolerated.
In honor of the 50th anniversary of ASCRS, member ophthalmologists from the 50 states are sending in their perspectives on the Society, its impact on…
SeaBeLife announced in vivo results for its SBL03 drug candidate, an ophthalmic gel designed to combat necrotic retinal cell death in g
Meet the newest innovation in the family of adjustability built on the Light Adjustable Lens platform—the Light Adjustable Lens+ (LAL+).
Learn about Glaucoma, Glaucoma signs and symptoms, and how to prevent blindness from Gluacoma
This study investigates the incidence and causes of diagnostic changes from primary open angle glaucoma suspect (POAGS) to primary open angle glaucoma (POAG), and vice…
This cohort study examines data for 63 patients over 12 months to assess how visual function and optical coherence tomography angiography changed in panretinal photocoagulation–treated…
AI has the potential to optimize and validate medical decision-making, with a particularly high expertise currently focused on ophthalmology.
The companies will work together by using the codon-optimized BBS1 AAV9 vector to minimize the vision loss caused by the genetic defects in the BBS1…
Dengue fever, a mosquito-borne illness caused by the dengue virus, affects millions globally, particularly in tropical and subtropical regions. Increasing reports of ocular manifestations in…
KOLOA, Hawaii — In this Healio Video Perspective from Retina 2025, Adrienne W. Scott, MD, of Johns Hopkins University School of Medicine, discusses her research…